PAREXEL® STRATEGIC PARTNERSHIPS

PAREXEL STRATEGIC
PARTNERSHIPS
®
Optimizing relationships for shorter time to market
YOUR JOURNEY.
OUR MISSION.
™
Delivering a more collaborative and operationally efficient relationship so
you can reach your drug development milestones faster and smarter
1
WORKING
SMARTER
BY WORKING
TOGETHER
PAREXEL is a pioneer in creating Strategic
Partnerships that enable biopharmaceutical
companies to optimize their clinical development.
As a global leader in clinical research services,
the company has more than 30 years of experience
collaborating with hundreds of the world’s most
successful biopharmaceutical organizations.
Biopharmaceutical companies that enter into Strategic
Partnerships with PAREXEL are able to:
•Leverage overhead and infrastructure
Complement internal knowledge with external
•
expertise
•Improve the predictability of their R&D efforts
•Rapidly expand global reach
•Increase operational efficiencies
•Streamline the development process
PAREXEL has the expertise and the global network to
serve biopharmaceutical companies of all sizes and
throughout all phases of development.
2
“TO MAKE CLINICAL DEVELOPMENT MORE
EFFECTIVE, PAREXEL INTERNATIONAL
HAS FORMULATED A MULTI-DISCIPLINARY
AND SYSTEMS-ORIENTED APPROACH
TO OUTSOURCED CLINICAL DEVELOPMENT,
BRINGING EFFICIENCIES, SCALABILITY,
AND STANDARDIZATION TO THE PROCESS.”
JOSEF VON RICKENBACH
CHAIRMAN AND CHIEF EXECUTIVE OFFICER
PAREXEL
ESSENTIAL BUILDING BLOCKS FOR
SUCCESSFUL STRATEGIC PARTNERSHIPS
Based on working with hundreds of biopharmaceutical
companies large and small and throughout all phases
of development, PAREXEL has the expertise to
understand what must be optimized to deliver results
and efficiencies in Strategic Partnerships.
The essential building blocks of successful partnering
relationships are based on:
Early Involvement. By engaging sponsors early in the
clinical trials process, PAREXEL helps establish better
protocols and operational plans, optimize performance,
improve efficiencies, and create the best course of
action to achieve results.
ell-Defined Financial Structures. With PAREXEL,
W
being able to put the correct financial structure
into place starts at the beginning of each partnership.
This includes the creation and tracking of financial
and operational metrics that will serve as indicators
of the relationship’s performance.
Strong Governance Framework. To help sponsors
A
retain quality trial performance while dedicating
substantially less time to CRO oversight, PAREXEL
creates detailed charters with regular review. This
helps to ensure that teams stay on track throughout
every partnership and each project.
Innovation Targets. PAREXEL’s systematic methodology
and approach to innovation focuses on cost, speed,
and quality. Defining innovation targets upfront
and measuring them regularly improves efficiencies,
accelerates cycle times, and reduces costs.
Transparency. In the most successful Strategic
Partnerships, both the CRO and sponsor collaborate
fully and communicate openly. For PAREXEL, effective
communications are managed and measured proactively
throughout the course of each project.
Performance Metrics. PAREXEL collaborates with
sponsors to define the metrics to measure the value
delivered around process improvement, cycle time
acceleration, quality increases, and solutions that
lower costs.
3
85%
OF EXECUTIVES BELIEVE
STRATEGIC PARTNERSHIPS
HAVE HAD A POSITIVE
IMPACT ON THE CROSPONSOR RELATIONSHIP.
Source: Strategic Partnerships 2013: Transforming and Unlocking Value in
Biopharmaceutical Development
Best Practices. Based on years of working closely with
biopharmaceutical leaders, PAREXEL recommends
and implements best practices around study startup,
technology use, trial site and patient recruitment, and
metrics to deliver greater value and more operational
efficiencies.
THE BEST STRATEGIC PARTNERSHIPS
DELIVER SIGNIFICANT VALUE
PAREXEL has developed its Strategic Partnerships
program to provide sponsors value by:
•Accelerating cycle times
Our regional leads are always available
for a conversation.
THE AMERICAS
James Anthony
+1 513 272 0055
james.anthony@PAREXEL.com
EUROPE
Graham Sanders
+44 (0) 1895 614319
graham.sanders@PAREXEL.com
•Improving quality
•Accessing innovation
ASIA PACIFIC
•Providing unique solutions to optimize research costs
Brian Yang
+886 2 2727 1100
asiabiz@PAREXEL.com
As the leading global CRO, PAREXEL has the experience
and the infrastructure to deliver on all aspects of
Strategic Partnerships. PAREXEL is committed
to creating partnerships that deliver value, drive
performance, and bring new drugs to market faster.
4
WHEREVER YOUR
JOURNEY TAKES YOU,
WE’RE CLOSE BY.
CORPORATE HEADQUARTERS
195 West Street
Waltham, MA 02451
USA
+1 781 487 9900
Offices across Europe, Asia and the Americas
www.PAREXEL.com
©2014 PAREXEL International Corporation. All rights reserved.